Compare ANIP & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIP | ABR |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2004 |
| Metric | ANIP | ABR |
|---|---|---|
| Price | $82.18 | $8.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $102.14 | $11.10 |
| AVG Volume (30 Days) | 395.1K | ★ 3.1M |
| Earning Date | 11-07-2025 | 10-31-2025 |
| Dividend Yield | N/A | ★ 14.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.67 | 0.80 |
| Revenue | ★ $826,880,000.00 | $552,909,000.00 |
| Revenue This Year | $43.41 | N/A |
| Revenue Next Year | $9.66 | N/A |
| P/E Ratio | $48.42 | ★ $10.52 |
| Revenue Growth | ★ 48.87 | N/A |
| 52 Week Low | $52.50 | $8.18 |
| 52 Week High | $99.50 | $14.55 |
| Indicator | ANIP | ABR |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 30.74 |
| Support Level | $79.98 | $8.76 |
| Resistance Level | $83.00 | $9.30 |
| Average True Range (ATR) | 2.18 | 0.27 |
| MACD | 0.28 | 0.02 |
| Stochastic Oscillator | 43.09 | 4.14 |
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.